178 related articles for article (PubMed ID: 37902011)
21. Management of parathyroid disorders: recommendations of the working group of the Bone Section of the Hellenic Endocrine Society.
Makras P; Yavropoulou MP; Kassi E; Anastasilakis AD; Vryonidou A; Tournis S
Hormones (Athens); 2020 Dec; 19(4):581-591. PubMed ID: 32297171
[TBL] [Abstract][Full Text] [Related]
22. Use of parathyroid hormone in hypoparathyroidism.
Cusano NE; Rubin MR; Irani D; Sliney J; Bilezikian JP
J Endocrinol Invest; 2013 Dec; 36(11):1121-7. PubMed ID: 24445125
[TBL] [Abstract][Full Text] [Related]
23. Is calcium supplementation always needed in patients with hypoparathyroidism?
Al-Sharefi A; Glenister E; Morris M; Quinton R
Clin Endocrinol (Oxf); 2019 Jun; 90(6):775-780. PubMed ID: 30801749
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of long-term management of patients with chronic post-surgical hypoparathyroidism.
Meola A; Vignali E; Matrone A; Cetani F; Marcocci C
J Endocrinol Invest; 2018 Oct; 41(10):1221-1226. PubMed ID: 29516386
[TBL] [Abstract][Full Text] [Related]
25. Five-year Estimated Glomerular Filtration Rate in Patients With Hypoparathyroidism Treated With and Without rhPTH(1-84).
Chen KS; Gosmanova EO; Curhan GC; Ketteler M; Rubin M; Swallow E; Zhao J; Wang J; Sherry N; Krasner A; Bilezikian JP
J Clin Endocrinol Metab; 2020 Oct; 105(10):e3557-65. PubMed ID: 32738041
[TBL] [Abstract][Full Text] [Related]
26. Mini-review: new therapeutic options in hypoparathyroidism.
Cusano NE; Rubin MR; Sliney J; Bilezikian JP
Endocrine; 2012 Jun; 41(3):410-4. PubMed ID: 22311174
[TBL] [Abstract][Full Text] [Related]
27. Hypoparathyroidism - management, information needs, and impact on daily living from the patients' perspective: results from a population-based survey.
Büttner M; Krogh D; Führer D; Fuß CT; Willenberg HS; Luster M; Singer S; Siggelkow H
Hormones (Athens); 2023 Sep; 22(3):467-476. PubMed ID: 37380916
[TBL] [Abstract][Full Text] [Related]
28. Drug safety evaluation of parathyroid hormone for hypocalcemia in patients with hypoparathyroidism.
Marcucci G; Della Pepa G; Brandi ML
Expert Opin Drug Saf; 2017 May; 16(5):617-625. PubMed ID: 28332412
[TBL] [Abstract][Full Text] [Related]
29. The Clinical and Skeletal Effects of Long-Term Therapy of Hypoparathyroidism With rhPTH(1-84).
Agarwal S; McMahon DJ; Chen J; Brossfield AV; Fernando J; Bilezikian JP; Cusano NE; Rubin MR
J Bone Miner Res; 2023 Apr; 38(4):480-492. PubMed ID: 36726204
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human parathyroid hormone (1-84) replacement therapy in a child with hypoparathyroidism.
Laurer E; Grünberger J; Naidoo U; Lanzersdorfer R; Wimleitner M; Tischlinger K; Högler W
Bone; 2021 Mar; 144():115834. PubMed ID: 33359892
[TBL] [Abstract][Full Text] [Related]
31. Complications, Symptoms, Presurgical Predictors in Patients With Chronic Hypoparathyroidism: A Systematic Review.
Yao L; Hui X; Li M; Li J; Ahmed MM; Lin C; Kandi M; Sreekanta A; Makhdami N; Tamilselvan D; Ali DS; Dandurand K; Yang K; Bilezikian JP; Brandi ML; Clarke BL; Mannstadt M; Rejnmark L; Khan AA; Guyatt G
J Bone Miner Res; 2022 Dec; 37(12):2642-2653. PubMed ID: 36375810
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis and management of hypocalcemia.
Pepe J; Colangelo L; Biamonte F; Sonato C; Danese VC; Cecchetti V; Occhiuto M; Piazzolla V; De Martino V; Ferrone F; Minisola S; Cipriani C
Endocrine; 2020 Sep; 69(3):485-495. PubMed ID: 32367335
[TBL] [Abstract][Full Text] [Related]
33. Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy.
Song Y; Li P; Lyu P; Yu Y; Chen X; Cui C; Bi R; Fan Y
J Vis Exp; 2023 Jul; (197):. PubMed ID: 37522721
[TBL] [Abstract][Full Text] [Related]
34. [Hypoparathyroidism treated with recombinant human parathyroid hormone [rhPTH(1-84)]].
Ramacciotti CF; Pereyra MC; Cohen EN
Medicina (B Aires); 2020; 80(3):289-291. PubMed ID: 32442945
[TBL] [Abstract][Full Text] [Related]
35. Bone Status Among Patients With Nonsurgical Hypoparathyroidism, Autosomal Dominant Hypocalcaemia, and Pseudohypoparathyroidism: A Cohort Study.
Underbjerg L; Malmstroem S; Sikjaer T; Rejnmark L
J Bone Miner Res; 2018 Mar; 33(3):467-477. PubMed ID: 29087612
[TBL] [Abstract][Full Text] [Related]
36. European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults.
Bollerslev J; Rejnmark L; Marcocci C; Shoback DM; Sitges-Serra A; van Biesen W; Dekkers OM;
Eur J Endocrinol; 2015 Aug; 173(2):G1-20. PubMed ID: 26160136
[TBL] [Abstract][Full Text] [Related]
37. Autosomal Dominant Hypocalcemia Type 1: A Systematic Review.
Roszko KL; Stapleton Smith LM; Sridhar AV; Roberts MS; Hartley IR; Gafni RI; Collins MT; Fox JC; Nemeth EF
J Bone Miner Res; 2022 Oct; 37(10):1926-1935. PubMed ID: 35879818
[TBL] [Abstract][Full Text] [Related]
38. Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium.
Winer KK; Sinaii N; Reynolds J; Peterson D; Dowdy K; Cutler GB
J Clin Endocrinol Metab; 2010 Jun; 95(6):2680-8. PubMed ID: 20392870
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in understanding and managing hypoparathyroidism.
Rubin MR
F1000Res; 2020; 9():. PubMed ID: 32765831
[TBL] [Abstract][Full Text] [Related]
40. PTH and bone material strength in hypoparathyroidism as measured by impact microindentation.
Starr JR; Tabacco G; Majeed R; Omeragic B; Bandeira L; Rubin MR
Osteoporos Int; 2020 Feb; 31(2):327-333. PubMed ID: 31720712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
